Liver International
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
Table of contents
- 1
-
Issue Information| 2023
- 6
-
Immune checkpoint inhibitors in malignancies after liver transplantation: Better safe or sorry?Vogel, Arndt / Lleo, Ana et al. | 2023
- 8
-
Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysisKayali, Stefano / Pasta, Andrea / Plaz Torres, Maria Corina et al. | 2023
- 18
-
Transjugular intrahepatic portosystemic shunt for portal hypertension: 30 years experience from ChinaLv, Yong / Fan, Daiming / Han, Guohong et al. | 2023
- 34
-
Immunogenicity of COVID‐19 vaccines in chronic liver disease patients and liver transplant recipients: A systematic review and meta‐analysisLuo, De / Chen, Xinpei / Du, Juan et al. | 2023
- 49
-
Improved survival of cirrhotic patients with infections in Australian and New Zealand ICUs between 2005 and 2017Majeed, Ammar / Bailey, Michael / Kemp, William et al. | 2023
- 60
-
Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to careJacob, Rachael / Prince, David S. / Pipicella, Joseph L. et al. | 2023
- 69
-
Predicting hepatitis B e Antigen seroconversion after pregnancy—The SydPregScoreThilakanathan, Cynthuja / Kayes, Tahrima / Di Girolamo, Julia et al. | 2023
- 77
-
A phase 2, open‐label, randomized, multiple‐dose study evaluating Inarigivir in treatment‐naïve patients with chronic hepatitis BYuen, Man‐Fung / Chen, Chi‐Yi / Liu, Chun‐Jen et al. | 2023
- 90
-
Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver diseaseBraude, Michael / Roberts, Stuart / Majeed, Ammar et al. | 2023
- 100
-
Altered ethanol metabolism and increased oxidative stress enhance alcohol‐associated liver injury in farnesoid X receptor‐deficient miceMorel, Caroline / Chowdhary, Vivek / Thevkar Nagesh, Prashanth et al. | 2023
- 115
-
A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI RegistryBjörnsson, Einar S. / Stephens, Camilla / Atallah, Edmond et al. | 2023
- 127
-
Impact on follow‐up strategies in patients with primary sclerosing cholangitisBergquist, Annika / Weismüller, Tobias J. / Levy, Cynthia et al. | 2023
- 139
-
Portal pressure is of significant prognostic value in primary biliary cholangitisWarnes, Thomas W. / Roberts, Stephen A. / Smith, Alexander et al. | 2023
- 147
-
Immune checkpoint inhibitor‐related cholangiopathy: Novel clinicopathological description of a multi‐centre cohortBerry, Philip / Kotha, Sreelakshmi / Zen, Yoh et al. | 2023
- 155
-
Increased platelet ratio in patients with decompensated cirrhosis indicates a higher risk of portal vein thrombosisZanetto, Alberto / Campello, Elena / Burra, Patrizia et al. | 2023
- 160
-
Sex is a major effect modifier between body composition and mortality in patients with cirrhosis assessed for liver transplantationBenmassaoud, Amine / Roccarina, Davide / Arico, Francesco Marcello et al. | 2023
- 170
-
FIB‐4 and incident severe liver outcomes in patients with undiagnosed chronic liver disease: A Fine‐Gray competing risk analysisSchreiner, Andrew D. / Zhang, Jingwen / Moran, William P. et al. | 2023
- 180
-
Pulmonary impairment independently determines mortality in critically ill patients with acute‐on‐chronic liver failureSchulz, Martin S. / Mengers, Jan / Gu, Wenyi et al. | 2023
- 194
-
TRIM27‐USP7 complex promotes tumour progression via STAT3 activation in human hepatocellular carcinomaSakamoto, Toshiya / Kuboki, Satoshi / Furukawa, Katsunori et al. | 2023
- 208
-
DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti‐DKK1 therapeutic DKN‐01Jarman, Edward J. / Horcas‐Lopez, Marta / Waddell, Scott H. et al. | 2023
- 221
-
Association of gut microbiome and primary liver cancer: A two‐sample Mendelian randomization and case–control studyMa, Jun / Li, Jialiang / Jin, Chen et al. | 2023
- 234
-
Apolipoprotein A‐1 protected hepatic ischaemia–reperfusion injury through suppressing macrophage pyroptosis via TLR4–NF‐κB pathwayChen, Rui‐Xiang / Jiang, Wang‐Jie / Liu, Shuo‐Chen et al. | 2023
- 249
-
Hepatic LeukaemiaPrasoppokakorn, Thaninee / Sanpavat, Anapat et al. | 2023
- 251
-
HCV point of care screening in people tested for SARS‐CoV‐2 in a social‐housing neighbourhood of Milan, ItalyBeltrami, Martina / Pagani, Gabriele / Conti, Federico et al. | 2023
- 256
-
Hepatitis delta virus infection in the Middle EastWaked, Imam et al. | 2023
- 257
-
Response to “Hepatitis delta virus infection in the Middle East”Alqahtani, Saleh A. / Sanai, Faisal M. / van Selm, Lena et al. | 2023
- 258
-
Alternative HCC prognostic biomarkers and use of artificial intelligence in the management of HCCJaffe, Ariel / Taddei, Tamar H. / Giannini, Edoardo G. et al. | 2023
- 260
-
Look for new biomarkers in the management of hepatocellular carcinoma: What the hepatologists may need to knowHuo, Teh‐Ia / Ho, Shu‐Yein / Liao, Jia‐I et al. | 2023